Caribou Biosciences, co-founded by campus researcher Jennifer Doudna, receives intellectual property rights for CRISPR technology

Ericka Shin.  The Daily Californian, 18 February 2016. http://www.dailycal.org/2016/02/18/caribou-biosciences-co-founded-campus-researcher-jennifer-doudna-receives-intellectual-property-rights-crispr-technology/

Caribou Biosciences, founded by UC Berkley professor Jennifer Doudna, was awarded a patent for the use of CRISPR/Cas9 technology in diagnostic applications.  This technique can be used to detect genomic rearrangements and is much narrower in scope than the CRISPR patents currently under dispute between UC Berkley and the Broad Institute.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply